2016 Archives
You are viewing archived information from 2016
Report Title: Opioid Antagonist; Naloxone Hydrochloride; Opioid Overdose; Prevention; Emergency Response; Medical Immunity
Description: Provides immunity for individuals and harm reduction organizations who prescribe, possess, or administer an opioid antagonist such as naloxone hydrochloride to prevent opioid-related drug overdoses. Authorizes emergency personnel and first responders to administer opioid antagonists. Requires medicaid coverage for opioid antagonists. Exempts individuals and harm reduction organizations from licensure and permitting requirements for storing and distributing opioid antagonists. Allows pharmacists, in accordance with standing orders and protocols, to dispense opioid antagonists to persons and harm reduction organizations without a prescription.
Companion:  SB2962
Package: None
Current Referral: HLT, CPC/JUD, FIN
Introducer(s): SOUKI

Sort by Date Status Text
2/1/2016HReferred to HLT, CPC/JUD, FIN, referral sheet 5
1/27/2016HIntroduced and Passed First Reading

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.

All Versions of this Measure

Committee Reports
No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.

No testimony available at this time.

Hearing Notices
No hearings scheduled